GSK takes control of China vaccines venture
June 15, 2011Manufacturing and Production, Research and Development, Sales and Marketing China, GSK, Shenzhen Neptunus Interlong Bio-Technique Co, vaccines
GlaxoSmithKline is increasing its footprint in China, shelling out £24 million ($39 million) to buy the remaining stake in a …
Arecor and GSK collaborate on vaccine technology
June 15, 2011Manufacturing and Production, Research and Development Arecor, GSK, vaccines
GSK is to team up with UK company Arecor to develop advanced formulations of GSK’s vaccines. Cambridge-based Arecor has developed …
Digital Pharma: Pharmacovigilance, the internet and social media
June 15, 2011Medical Communications, Research and Development, Sales and Marketing Digital Pharma blog, adverse event reporting, adverse events, pharmacovigilance
This week the ABPI released guidance on managing adverse events from social media and the internet in a document that …
Teva’s Cephalon acquisition could be delayed
June 15, 2011Manufacturing and Production, Research and Development, Sales and Marketing Cephalon, Teva
The Federal Trade Commission has requested more information about Teva’s deal with Cephalon, potentially delaying the purchase by a month. …
Merck to develop biosimilar of Pfizer’s Enbrel
June 15, 2011Research and Development, Sales and Marketing Enbrel, Merck & Co, biosimilar
Merck & Co is to develop its own version of Pfizer’s ageing arthritis drug Enbrel with a South Korean manufacturer. …
Future Forum recommends major amendments to Health Bill
June 14, 2011Health and Social Care Bill, NHS reforms
The role of GPs and competition in the government’s Health Bill should be greatly diluted and its reform programme substantially …
Xceleron appoints Dr Stuart Best
June 14, 2011Manufacturing and Production, Research and Development appointment, manufacturing and production, research and development
Dr Stuart Best has joined Xceleron as senior director operations, moving to the company from Merck in Scotland where he …
FDA plea for notice on drug shortages
June 14, 2011Manufacturing and Production FDA, pharma manufacturing
The FDA has asked US drugmakers to give advance warning of production problems which could lead to shortages in available …
Pharma manufacturing news in brief
June 14, 2011Manufacturing and Production pharma manufacturing
Baxter loses first heparin lawsuit, Pfizer plans a branded generics push in China, plus there’s updates from GSK, Hovione and …
Pfizer’s Sandwich site on market as ‘discovery park’
June 14, 2011Research and Development Pfizer, Sandwich, UK pharma
Pfizer has expanded its options for its main European research site, earmarked for closure in Feburary, and is now marketing …
Merck redesigns drug labels for clarity
June 14, 2011Manufacturing and Production FDA, Labelling, Merck & Co
The FDA has approved a major overhaul of labelling for a range of Merck & Co products, paving the way …
Digital Pharma: The rise of the European e-patient
June 14, 2011Medical Communications, Sales and Marketing Digital Pharma blog, online health information
The number of people in Europe who go online to look for health information has more than doubled over the …
Innovation – is it science or art?
June 14, 2011Manufacturing and Production, Research and Development creativity, drug development, innovation
In recent times new drug development has shown a substantial decline in the number of approved drugs for human use. …
Gilead manufacturing under investigation by US authorities
June 14, 2011Manufacturing and Production Department of Justice, Gilead, manufacturing compliance, pharma manufacturing
Gilead Sciences is being investigated by the US authorities over the manufacturing and distribution of some of its products, and …
Brand(x) rebrands to ICC Lowe
June 13, 2011Medical Communications Brand(x), ICC Lowe, medical communications
Brand(x) is changing its name to ICC Lowe and will act as the London office for its expanding US parent …
Merck KGaA readies phase III brain cancer trial
June 13, 2011Research and Development Merck KGaA, brain cancer, cilengitide, glioblastoma
Merck KGaA has completed patient enrollment for a phase III global trial of its first-in-class integrin inhibitor in a rare …
Daniel Elger joins e-Therapeutics
June 13, 2011Research and Development, Sales and Marketing appointment, research and development, sales and marketing
UK and India-based e-Therapeutics has appointed Dr Daniel Elger as chief financial officer. He joins the drug discovery company from …
Networks in Health appoints Beverly Stainsby
June 13, 2011Sales and Marketing appointment, sales and marketing
Beverly Stainsby has joined Networks in Health, an alliance of online doctors’ communities, as international account director. She joins from …
European pharma’s compliance challenge
June 13, 2011Sales and Marketing global regulatory landscape, regulatory affairs, regulatory compliance
Life Sciences companies across Europe are facing a series of emerging global legislation and increased regulatory enforcement, designed to prevent …
GSK’s epilepsy treatment Potiga wins US approval
June 13, 2011Sales and Marketing GSK, Potiga, Trobalt, Valeant, epilepsy
The FDA has approved GlaxoSmithKline and Valeant’s epilepsy treatment Potiga, but the drug will require further review before it can …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
